Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity

Area of Science:

• Cardiovascular Science
• Biochemistry
• Pharmacology

Background:

• Apolipoprotein A-I (ApoA-I) and high-density lipoprotein (HDL) are crucial for preventing atherosclerosis.
• Several compounds, including drugs and alcohol, are known to increase ApoA-I synthesis.

Purpose of the Study:

• To review the mechanisms by which various compounds induce ApoA-I and HDL production.
• To highlight the antiatherogenic effects and therapeutic potential of these inducers.

Main Methods:

• Review of existing literature on compounds that affect ApoA-I and HDL metabolism.
• Analysis of the molecular mechanisms underlying the antiatherogenic actions of these compounds.

Main Results:

• Inducers of ApoA-I synthesis lead to favorable lipoprotein profiles and reduced coronary heart disease risk.
• Mechanisms include increased ApoA-I/HDL, enhanced reverse cholesterol transport, and improved endothelial function.
• Compounds also inhibit low-density lipoprotein (LDL) oxidation and possess anti-inflammatory and anti-thrombotic properties.

Conclusions:

• Gene activation and microsomal induction by these compounds offer a promising strategy for preventing atherosclerosis.
• Targeting ApoA-I and HDL pathways can lead to effective therapies for atherosclerotic vascular disease.
• This approach holds potential for promoting cardiovascular health and increasing longevity.